News
French pharmaceutical and healthcare company Sanofi has agreed to buy the British biotechnology firm Vicebio for up to $1.6bn ...
6d
Dealbreaker on MSNSanofi Extends Respiratory Vaccines Reach With $1.15B Acquisition of Clinical-Stage Vicebio
The deal complements an existing partnership with Novavax that encompasses R&D of combination vaccines for Covid-19 and flu.
Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...
Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.
5d
Investing News Network on MSNBiotech and Pharma Market Update: Q2 2025 in Review
The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
3d
News-Medical.Net on MSNNew model predicts mRNA protein production, accelerating drug and vaccine discovery
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...
The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...
Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...
Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results